Review of Ophthalmology BETA > Making the Most Of FDA’s MedWatch | Teaching | Scoop.it
After a drug is approved, you and your patients are the last line of defense against adverse events. (Learn about FDA's MedWatch and reporting adverse events in the new issue of Review of Ophthalmology http://t.co/Xn9JyO1 @FDAMedWatch #FDA)
Via JFGirmens